Activity value 72International Buyer&Supplier,Last transaction date:
2025-11-10
Overview
Import data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for german quality pharma inc. from 2024 to 2025.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2025, the company has completed 14 transactions, with a transaction quantity of 397 and a transaction weight of 2126.
YearTransactionsQuantityWeight
202419502920.53
2025143972126
Bill of lading data
<
1/15
>
Trade date
2025/11/10
B/L No.
dsbg2511004
Suppliers
nobamedi co.ltd.
Buyers
german quality pharma inc.
german quality pharma inc. is International Buyer&Supplier,
and primarily engages in the import and export business of products such as pc,mult,injector.
According to the 52wmb.com global trade database, as of 2025-11-10, the company has completed 157 international trades,
with its main trading regions covering costa rica,philippines,south korea etc.
The core products include HS90189090000,HS33049990000,HS21069072000 etc,
often transported via manila,port ninoy aquino international airport, port manila international container terminal etc,
and its main trading partners are nobamedi co.ltd.,benemedo gmbh,apple biotech.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on german quality pharma inc. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.